Ascendas Genomics specializes in advanced microfluidic technologies that enhance the efficiency and accuracy of genomic testing. Their flagship product, the microfluidic ultra-multiplex qPCR system, integrates a microfluidic nucleic acid amplifier with a real-time fluorescence PCR analyzer. This combination allows for automated, high-throughput, and cost-effective PCR reactions, enabling a wide range of applications such as gene expression analysis, genotyping, copy number variation analysis, and protein biomarker detection. The system is designed to minimize contamination risks and supports a flexible, multiplexed approach to molecular diagnostics, accommodating various commercial probe and dye methods without the need for pre-embedding.

In addition to their qPCR system, Ascendas Genomics offers a high-throughput sequencing library construction capability when paired with sequencing instruments. Their real-time fluorescence PCR analyzer is capable of generating up to 9216 data points in a single run, processing as many as 192 samples in approximately three hours. This technology is particularly beneficial for clinical molecular diagnostics, providing solutions for infectious disease control, precision medicine, and public health applications. The company is committed to advancing the field of clinical genomics and life sciences through innovative microfluidic solutions.

China

The company specializes in the development of genetic testing programs, medical testing reagents and bioinformatics data analysis management software.

Ascendas Genomics

Company Details